Table 2. Effect of LOS or PKCγ siRNA on MDA, SOD, GSH levels and NAD(P)H oxidase activity in PVN of salt-induced hypertensive and control groups (n = 7, for each group).

PVN	MDA (mmol/mgp)	SOD (U/mgp)	GSH (umol/mgp)	NAD(P)H oxidase (RLU/mg/sec)
HS + PVN LOS	4.87 ± 0.19†,∗	6.26 ± 0.30†,∗	2.85 ± 0.24†,∗	1.91 ± 1.20†,∗
HS + PVN aCSF	7.01 ± 0.24∗	2.67 ± 0.10∗	0.98 ± 0.13∗	3.69 ± 1.41∗
NS + PVN LOS	1.68 ± 0.22	9.61 ± 0.40	4.76 ± 0.15	0.93 ± 0.34
NE + PVN aCSF	1.25 ± 0.21	10.00 ± 1.40	5.18 ± 0.37	0.87 ± 0.29
HS + PVN PKC siRNA	3.82 ± 0.14†,∗	4.57 ± 0.17†,∗	1.99 ± 0.18†,∗	2.80 ± 1.16†,∗
HS + PVN scrambled siRNA	6.28 ± 0.24∗	3.67 ± 0.15∗	0.98 ± 0.13∗	4.27 ± 1.78∗
NS + PVN PKC siRNA	2.55 ± 0.13	7.11 ± 0.37	3.24 ± 0.12	1.33 ± 0.32
NE + PVN scrambled siRNA	2.68 ± 0.14	7.85 ± 0.44	2.97 ± 0.11	1.18 ± 0.26

Values are expressed as means SE. *P < 0.05 versus NS groups; ^†P < 0.05 HS + PVN LOS or HS + PVN PKC siRNA versus HS control groups.